raloxifene hydrochloride has been researched along with deoxypyridinoline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélanger, A; Labrie, C; Labrie, F; Martel, C; Picard, S; Richard, V | 1 |
| Akazawa, K | 1 |
| Mossetti, G; Nappi, C; Numis, FG; Nunziata, V; Palomba, S; Rendina, D; Russo, T; Vuotto, P; Zullo, F | 1 |
| Draper, MW; Herrmann, F; Pavo, I; Rizzoli, R; Uebelhart, B | 1 |
| Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ | 1 |
| Aydin, K; Guclu, F; Hekimsoy, Z; Kafesciler, SO; Kirmaz, C; Ozmen, B | 1 |
| Allen, MR; Burr, DB; Delmas, PD; Gineyts, E; Leeming, DJ | 1 |
| Inaba, M; Shidara, K | 1 |
2 review(s) available for raloxifene hydrochloride and deoxypyridinoline
| Article | Year |
|---|---|
[Advance in the treatment of postmenopausal osteoporosis].
Topics: Aged; Amino Acids; Biomarkers; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Procollagen; Quality of Life; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
[Bone metabolic marker for osteoporosis].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Collagen Type I; Diphosphonates; Female; Fractures, Bone; Humans; Isoenzymes; Osteoporosis; Peptides; Raloxifene Hydrochloride; Risk Assessment; Tartrate-Resistant Acid Phosphatase | 2009 |
2 trial(s) available for raloxifene hydrochloride and deoxypyridinoline
| Article | Year |
|---|---|
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Topics: Aged; Amino Acids; Biomarkers; Bone Remodeling; Creatine; Cross-Over Studies; Double-Blind Method; Estradiol; Health; Humans; Male; Middle Aged; Placebos; Raloxifene Hydrochloride; Testosterone | 2004 |
Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Topics: Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Cytokines; Female; Humans; Interleukin-6; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin D | 2007 |
4 other study(ies) available for raloxifene hydrochloride and deoxypyridinoline
| Article | Year |
|---|---|
Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Topics: Administration, Oral; Amino Acids; Animals; Benzopyrans; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Cholesterol; Disease Models, Animal; Epithelial Cells; Estradiol; Estrogens; Female; Femur; Lumbar Vertebrae; Organ Size; Ovariectomy; Postmenopause; Propionates; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Time Factors; Triglycerides; Uterus | 2000 |
Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.
Topics: Aged; Amino Acids; Bone Density; Double-Blind Method; Female; Genotype; Heterozygote; Homozygote; Humans; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Polymorphism, Genetic; Raloxifene Hydrochloride; Receptors, Calcitriol; Selective Estrogen Receptor Modulators | 2003 |
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing | 2005 |
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
Topics: Alendronate; Amino Acids; Animals; Arginine; Bone Density Conservation Agents; Bone Remodeling; Collagen; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Female; Lumbar Vertebrae; Lysine; Raloxifene Hydrochloride; Risedronic Acid | 2008 |